Gene Therapy For Parkinson's Disease

This week, the first clinical trial of gene therapy for Parkinson's disease began. We'll talk about this experimental treatment.

Guests:

Michael Kaplitt, M.D., Ph.D.
* Assistant Professor, Neurological Surgery Weill Cornell Medical College
* Director, Center for Stereotactic and Functional Neurosurgery, New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York

Theodore Friedmann, M.D.
*Chair, Recombinant DNA Advisory Committee (RAC), National Institutes of Health Professor, Pediatrics
* Muriel Jeannette Whitehill Chair in Biomedical Ethics
* Director, Program in Human Gene Therapy University of California San Diego, San Diego, California

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.